Comparison of Quality of Recovery (QoR)-15 Scores Between Propofol and Remimazolam Anesthesia
NCT ID: NCT05016518
Last Updated: 2022-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2021-09-16
2022-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Postoperative QoR-15 Scores Between Propofol and Remimazolam
NCT04994704
Comparison of Recovery Profile After TIVA Between Remimazolam With Flumazenil and Propofol
NCT05047939
Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery
NCT06507202
The Effect of Remimazolam on Postoperative Sleep Quality
NCT07094945
The Comparison of Remimazolam With Propofol in Core Body Temperature
NCT05215834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Propofol group
Propofol based total intravenous anesthesia
Arm I (Propofol group)
Propfol group will be started and maintained total intravenous anesthesia with propofol and remifentanil .
Remimazolam group
Remimazolam based total intravenous anesthesia
Arm II (Remimazolam group)
Remimazolam group will be started and maintained total intravenous anesthesia with remimazolam and remifentanil.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arm I (Propofol group)
Propfol group will be started and maintained total intravenous anesthesia with propofol and remifentanil .
Arm II (Remimazolam group)
Remimazolam group will be started and maintained total intravenous anesthesia with remimazolam and remifentanil.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Taking any sedative, opioid, or sleep aid drugs
* Psychiatric or neurological disorder
* BMI\>30 kg/m2
* Pregnancy
* Vulnerable patients
20 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gangnam Severance Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Young Song
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Young Song
Role: PRINCIPAL_INVESTIGATOR
GangnamSeverance Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gangnam Severance Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-0424-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.